| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.887 | 0.001 | 0.887 | Endothelin A receptor antagonist | 0.645 0.001 DBMET01405 0.833 0.001 DBMET00460 0.595 0.001 DBMET01406 | ||
| 0.884 | 0.001 | 0.884 | Endothelin receptor antagonist | 0.64 0.002 DBMET01405 0.819 0.001 DBMET00460 0.591 0.002 DBMET01406 | ||
| 0.847 | 0.004 | 0.847 | Cardiotonic | 0.624 0.007 DBMET01405 0.812 0.004 DBMET00460 0.596 0.008 DBMET01406 | ||
| 0.832 | 0.001 | 0.832 | Endothelin B receptor antagonist | 0.557 0.002 DBMET01405 0.757 0.001 DBMET00460 0.484 0.002 DBMET01406 | ||
| 0.676 | 0.01 | 0.676 | Toll-Like receptor 7 agonist | 0.335 0.09 DBMET01405 0.671 0.011 DBMET00460 0.365 0.075 DBMET01406 | ||
| 0.673 | 0.01 | 0.673 | Toll-Like receptor agonist | 0.353 0.08 DBMET01405 0.67 0.011 DBMET00460 0.385 0.067 DBMET01406 | ||
| 0.444 | 0.054 | 0.608 | Calcium channel L-type activator | 0.253 0.202 DBMET01405 0.608 0.005 DBMET00460 0.525 0.019 DBMET01406 | DBMET00460 | |
| 0.391 | 0.058 | 0.514 | Vasodilator, peripheral | 0.372 0.065 DBMET01405 0.514 0.025 DBMET00460 0.496 0.028 DBMET01406 | DBMET00460 | |
| 0.309 | 0.038 | 0.477 | Cyclic AMP phosphodiesterase inhibitor | 0.37 0.021 DBMET01405 0.416 0.014 DBMET00460 0.477 0.008 DBMET01406 | DBMET01406 | |
| 0.337 | 0.07 | 0.592 | Cholesterol antagonist | 0.553 0.025 DBMET01405 0.373 0.056 DBMET00460 0.592 0.02 DBMET01406 | DBMET01406 | |
| 0.305 | 0.087 | 0.318 | Calcium channel activator | 0.318 0.075 DBMET00460 | DBMET00460 | |
| 0.182 | 0.006 | 0.251 | Leukotriene synthesis inhibitor | 0.091 0.031 DBMET01405 0.251 0.005 DBMET00460 0.128 0.014 DBMET01406 | DBMET00460 | |
| 0.319 | 0.145 | 0.319 | 5 Hydroxytryptamine release inhibitor | 0.269 0.203 DBMET01405 | ||
| 0.155 | 0.012 | 0.155 | Peroxisome proliferator-activated receptor gamma agonist | 0.137 0.016 DBMET00460 | ||
| 0.178 | 0.042 | 0.209 | Alpha-N-acetylglucosaminidase inhibitor | 0.209 0.031 DBMET01405 0.171 0.044 DBMET00460 0.202 0.034 DBMET01406 | DBMET01405 | |
| 0.167 | 0.037 | 0.189 | Interleukin 4 antagonist | 0.189 0.026 DBMET01405 0.145 0.054 DBMET00460 0.169 0.035 DBMET01406 | DBMET01405 | |
| 0.143 | 0.015 | 0.143 | Interleukin 12 antagonist | 0.126 0.024 DBMET01405 0.128 0.023 DBMET00460 0.116 0.033 DBMET01406 | ||
| 0.129 | 0.004 | 0.129 | Heme oxygenase stimulant | 0.1 0.007 DBMET01405 0.114 0.005 DBMET00460 0.091 0.009 DBMET01406 | ||
| 0.172 | 0.048 | 0.172 | Mannose-6-phosphate isomerase inhibitor | 0.147 0.067 DBMET01405 0.133 0.082 DBMET00460 0.115 0.109 DBMET01406 | ||
| 0.155 | 0.036 | 0.18 | 5-Lipoxygenase inhibitor | 0.18 0.029 DBMET00460 | DBMET00460 | |
| 0.166 | 0.058 | 0.166 | Protein kinase stimulant | 0.156 0.064 DBMET01405 0.161 0.061 DBMET00460 0.151 0.067 DBMET01406 | ||
| 0.109 | 0.007 | 0.109 | Aconitate hydratase inhibitor | 0.066 0.021 DBMET00460 | ||
| 0.167 | 0.069 | 0.167 | Arachidonic acid antagonist | 0.142 0.098 DBMET00460 | ||
| 0.124 | 0.03 | 0.132 | Triose-phosphate isomerase inhibitor | 0.132 0.026 DBMET01405 0.118 0.033 DBMET00460 0.126 0.029 DBMET01406 | DBMET01405 | |
| 0.235 | 0.149 | 0.383 | Vasodilator, coronary | 0.322 0.071 DBMET01405 0.294 0.092 DBMET00460 0.383 0.041 DBMET01406 | DBMET01406 | |
| 0.131 | 0.045 | 0.131 | Mucolytic | 0.116 0.058 DBMET00460 | ||
| 0.111 | 0.028 | 0.131 | Phosphofructokinase-1 inhibitor | 0.131 0.022 DBMET01405 0.106 0.029 DBMET00460 0.126 0.024 DBMET01406 | DBMET01405 | |
| 0.123 | 0.041 | 0.123 | Adenylate kinase inhibitor | 0.102 0.065 DBMET00460 | ||
| 0.2 | 0.12 | 0.508 | Immunostimulant | 0.498 0.029 DBMET01405 0.209 0.115 DBMET00460 0.508 0.028 DBMET01406 | DBMET01406 | |
| 0.176 | 0.1 | 0.176 | Insulin sensitizer | 0.156 0.125 DBMET00460 | ||
| 0.187 | 0.112 | 0.187 | Aldehyde oxidase inhibitor | |||
| 0.163 | 0.09 | 0.163 | Succinate dehydrogenase inhibitor | |||
| 0.158 | 0.088 | 0.194 | ATPase inhibitor | 0.194 0.042 DBMET01405 | DBMET01405 | |
| 0.147 | 0.082 | 0.237 | Interferon gamma antagonist | 0.237 0.031 DBMET01405 0.133 0.104 DBMET00460 0.204 0.039 DBMET01406 | DBMET01405 | |
| 0.102 | 0.039 | 0.102 | Interleukin 5 antagonist | 0.084 0.065 DBMET01405 0.09 0.054 DBMET00460 | ||
| 0.124 | 0.062 | 0.124 | Cholesterol synthesis inhibitor | |||
| 0.094 | 0.034 | 0.094 | Glutamate dehydrogenase inhibitor | 0.07 0.056 DBMET00460 | ||
| 0.106 | 0.049 | 0.106 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.089 0.066 DBMET00460 | ||
| 0.138 | 0.081 | 0.144 | Ca2+-transporting ATPase inhibitor | 0.144 0.061 DBMET01405 0.131 0.113 DBMET01406 | DBMET01405 | |
| 0.113 | 0.058 | 0.113 | Ferrochelatase inhibitor | |||
| 0.081 | 0.028 | 0.081 | Carbamoyl phosphate synthetase inhibitor | 0.063 0.04 DBMET00460 | ||
| 0.091 | 0.038 | 0.111 | Interferon agonist | 0.111 0.021 DBMET01405 0.083 0.047 DBMET00460 0.102 0.027 DBMET01406 | DBMET01405 | |
| 0.057 | 0.011 | 0.057 | Fumarate hydratase inhibitor | 0.039 0.019 DBMET00460 | ||
| 0.075 | 0.029 | 0.093 | Interferon inducer | 0.093 0.015 DBMET01405 0.069 0.036 DBMET00460 0.086 0.019 DBMET01406 | DBMET01405 | |
| 0.15 | 0.105 | 0.15 | Lipocortins synthesis antagonist | |||
| 0.106 | 0.063 | 0.198 | Expectorant | 0.198 0.021 DBMET01405 0.092 0.078 DBMET00460 0.173 0.027 DBMET01406 | DBMET01405 | |
| 0.081 | 0.042 | 0.081 | Histidine decarboxylase inhibitor | 0.072 0.049 DBMET00460 | ||
| 0.067 | 0.03 | 0.067 | Alcohol oxidase inhibitor | |||
| 0.057 | 0.021 | 0.057 | Glucose-6-phosphate isomerase inhibitor | 0.055 0.023 DBMET01405 0.056 0.022 DBMET00460 0.055 0.023 DBMET01406 | ||
| 0.091 | 0.055 | 0.168 | NADH dehydrogenase inhibitor | 0.168 0.014 DBMET01405 0.088 0.059 DBMET00460 0.163 0.015 DBMET01406 | DBMET01405 | |
| 0.076 | 0.041 | 0.076 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.128 | 0.093 | 0.128 | Peroxidase inhibitor | |||
| 0.193 | 0.159 | 0.193 | Gastrin inhibitor | |||
| 0.209 | 0.176 | 0.209 | Sodium/bile acid cotransporter inhibitor | |||
| 0.185 | 0.157 | 0.185 | Lipoxygenase inhibitor | 0.18 0.164 DBMET00460 | ||
| 0.187 | 0.16 | 0.187 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.147 | 0.12 | 0.147 | Interleukin antagonist | |||
| 0.082 | 0.057 | 0.082 | Thioredoxin reductase inhibitor | 0.078 0.067 DBMET01405 0.081 0.059 DBMET00460 0.078 0.067 DBMET01406 | ||
| 0.061 | 0.04 | 0.061 | Biliverdin reductase inhibitor | |||
| 0.072 | 0.053 | 0.072 | Glutamate decarboxylase inhibitor | |||
| 0.07 | 0.056 | 0.07 | Porphobilinogen synthase inhibitor | |||
| 0.095 | 0.083 | 0.095 | Cystathionine beta-synthase inhibitor | |||
| 0.067 | 0.057 | 0.067 | Catalase inhibitor | |||
| 0.036 | 0.03 | 0.036 | Glutamate (mGluR8) agonist | |||
| 0.032 | 0.027 | 0.032 | Free fatty acid receptor 1 antagonist | 0.032 0.026 DBMET00460 | ||
| 0.069 | 0.067 | 0.069 | Keratolytic | |||
| 0.159 | 0.164 | 0.365 | Hypoglycemic | 0.355 0.037 DBMET01405 0.19 0.122 DBMET00460 0.365 0.034 DBMET01406 | DBMET01406 | |
| 0.158 | 0.174 | 0.335 | Peptidyltransferase inhibitor | 0.335 0.015 DBMET01405 0.312 0.021 DBMET01406 | DBMET01405 | |
| 0.124 | 0.144 | 0.351 | Hepatoprotectant | 0.342 0.02 DBMET01405 0.167 0.092 DBMET00460 0.351 0.019 DBMET01406 | DBMET01406 | |
| 0.222 | 0.245 | 0.463 | Cyclophilin D inhibitor | 0.441 0.07 DBMET01405 0.285 0.176 DBMET00460 0.463 0.062 DBMET01406 | DBMET01406 | |
| 0.13 | 0.16 | 0.15 | Hypolipemic | 0.145 0.142 DBMET01405 0.15 0.137 DBMET01406 | DBMET01406 | |
| 0.04 | 0.071 | 0.055 | Alpha-mannosidase inhibitor | 0.054 0.036 DBMET01405 0.055 0.035 DBMET01406 | DBMET01406 | |
| 0.085 | 0.12 | 0.142 | Microtubule formation inhibitor | 0.142 0.042 DBMET01405 0.112 0.071 DBMET01406 | DBMET01405 | |
| 0.184 | 0.223 | 0.24 | Histamine release inhibitor | 0.24 0.163 DBMET01405 0.216 0.185 DBMET01406 | DBMET01405 | |
| 0.045 | 0.085 | 0.078 | Adenine nucleotide translocase inhibitor | 0.078 0.01 DBMET01405 0.076 0.011 DBMET01406 | DBMET01405 | |
| 0.068 | 0.116 | 0.192 | UDP-glucose 4-epimerase inhibitor | 0.19 0.019 DBMET01405 0.192 0.019 DBMET01406 | DBMET01406 | |
| 0.026 | 0.078 | 0.045 | Mannosidase inhibitor | 0.043 0.034 DBMET01405 0.045 0.032 DBMET01406 | DBMET01406 | |
| 0.064 | 0.127 | 0.087 | ATPase (Vacuolar H+) inhibitor | 0.087 0.062 DBMET01405 | DBMET01405 | |
| 0.031 | 0.101 | 0.302 | Selectin antagonist | 0.302 0.005 DBMET01405 0.301 0.005 DBMET01406 | DBMET01405 | |
| 0.145 | 0.215 | 0.237 | DNA synthesis inhibitor | 0.237 0.076 DBMET01405 0.23 0.083 DBMET01406 | DBMET01405 | |
| 0.071 | 0.148 | 0.155 | Toll-Like receptor 4 antagonist | 0.155 0.019 DBMET01405 0.149 0.021 DBMET01406 | DBMET01405 | |
| 0.01 | 0.089 | 0.02 | Antibiotic Anthracycline-like | 0.02 0.01 DBMET01405 | DBMET01405 | |
| 0.101 | 0.183 | 0.127 | Melanin inhibitor | 0.127 0.12 DBMET01405 | DBMET01405 | |
| 0.043 | 0.132 | 0.059 | Lipocortins synthesis agonist | 0.059 0.037 DBMET01405 0.056 0.044 DBMET01406 | DBMET01405 | |
| 0.036 | 0.131 | 0.068 | Na+ K+ transporting ATPase inhibitor | 0.068 0.062 DBMET01405 | DBMET01405 | |
| 0.071 | 0.169 | 0.175 | Cyclooxygenase 3 inhibitor | 0.175 0.03 DBMET01405 0.169 0.034 DBMET01406 | DBMET01405 | |
| 0.208 | 0.309 | 0.332 | Caspase 9 stimulant | 0.332 0.161 DBMET01405 0.284 0.211 DBMET01406 | DBMET01405 | |
| 0.03 | 0.138 | 0.064 | Heparanase inhibitor | 0.064 0.018 DBMET01405 0.058 0.026 DBMET01406 | DBMET01405 | |
| 0.147 | 0.256 | 0.372 | Antithrombotic | 0.34 0.068 DBMET01405 0.372 0.057 DBMET01406 | DBMET01406 | |
| 0.06 | 0.171 | 0.177 | Amylase inhibitor | 0.177 0.052 DBMET01405 0.164 0.058 DBMET01406 | DBMET01405 | |
| 0.022 | 0.134 | 0.087 | Protein 50S ribosomal subunit inhibitor | 0.087 0.017 DBMET01405 0.079 0.02 DBMET01406 | DBMET01405 | |
| 0.057 | 0.17 | 0.136 | Transcription factor NF kappa B stimulant | 0.136 0.019 DBMET01405 0.136 0.019 DBMET01406 | DBMET01406 | |
| 0.089 | 0.208 | 0.313 | Nitric oxide antagonist | 0.313 0.038 DBMET01405 0.297 0.041 DBMET01406 | DBMET01405 | |
| 0.078 | 0.203 | 0.166 | Cell wall synthesis inhibitor | 0.166 0.051 DBMET01405 0.153 0.063 DBMET01406 | DBMET01405 | |
| 0.022 | 0.151 | 0.067 | Microtubule stabilization | 0.067 0.008 DBMET01405 0.064 0.01 DBMET01406 | DBMET01405 | |
| 0.096 | 0.226 | 0.15 | Non-steroidal antiinflammatory agent | 0.147 0.119 DBMET01405 0.15 0.114 DBMET01406 | DBMET01406 | |
| 0.054 | 0.191 | 0.123 | DNA polymerase I inhibitor | 0.122 0.067 DBMET01405 0.123 0.066 DBMET01406 | DBMET01406 | |
| 0.025 | 0.165 | 0.046 | Cytokine production stimulant | 0.046 0.041 DBMET01406 | DBMET01406 | |
| 0.083 | 0.226 | 0.141 | Insulin secretagoues | 0.141 0.084 DBMET01405 | DBMET01405 | |
| 0.036 | 0.181 | 0.103 | Monophenol monooxygenase inhibitor | 0.103 0.073 DBMET01405 | DBMET01405 | |
| 0.016 | 0.164 | 0.029 | Toll-Like receptor 4 agonist | 0.029 0.012 DBMET01405 0.029 0.013 DBMET01406 | DBMET01406 | |
| 0.007 | 0.165 | 0.035 | Sodium/glucose cotransporter 2 inhibitor | 0.027 0.016 DBMET01405 0.035 0.01 DBMET01406 | DBMET01406 | |
| 0.056 | 0.216 | 0.171 | Thrombolytic | 0.162 0.073 DBMET01405 0.171 0.067 DBMET01406 | DBMET01406 | |
| 0.081 | 0.246 | 0.22 | Interleukin agonist | 0.22 0.103 DBMET01405 0.195 0.125 DBMET01406 | DBMET01405 | |
| 0.019 | 0.185 | 0.137 | Antineoplastic antibiotic | 0.137 0.034 DBMET01405 0.119 0.039 DBMET01406 | DBMET01405 | |
| 0.093 | 0.262 | 0.314 | Vasodilator | 0.275 0.057 DBMET01405 0.155 0.149 DBMET00460 0.314 0.044 DBMET01406 | DBMET01406 | |
| 0.085 | 0.259 | 0.165 | Spasmolytic | 0.165 0.15 DBMET01406 | DBMET01406 | |
| 0.008 | 0.192 | 0.03 | Sodium/glucose cotransporter inhibitor | 0.026 0.017 DBMET01405 0.03 0.011 DBMET01406 | DBMET01406 | |
| 0.018 | 0.205 | 0.059 | Antibiotic Aminoglycoside-like | 0.059 0.009 DBMET01405 0.059 0.009 DBMET01406 | DBMET01406 | |
| 0.024 | 0.214 | 0.053 | Glucose-6-phosphate translocase inhibitor | 0.053 0.033 DBMET01405 0.049 0.042 DBMET01406 | DBMET01405 | |
| 0.138 | 0.333 | 0.406 | Interleukin 2 agonist | 0.404 0.026 DBMET01405 0.406 0.026 DBMET01406 | DBMET01406 | |
| 0.074 | 0.276 | 0.147 | Hemostatic | 0.147 0.072 DBMET01405 0.131 0.094 DBMET01406 | DBMET01405 | |
| 0.04 | 0.259 | 0.13 | Alkylator | 0.127 0.062 DBMET01405 0.13 0.059 DBMET01406 | DBMET01406 | |
| 0.079 | 0.308 | 0.437 | Antioxidant | 0.437 0.029 DBMET01405 0.408 0.034 DBMET01406 | DBMET01405 | |
| 0.048 | 0.301 | 0.164 | Cell adhesion inhibitor | 0.164 0.038 DBMET01405 0.127 0.06 DBMET01406 | DBMET01405 | |
| 0.065 | 0.334 | 0.146 | DNA repair enzyme inhibitor | 0.133 0.051 DBMET01405 0.146 0.035 DBMET01406 | DBMET01406 | |
| 0.079 | 0.357 | 0.455 | Transcription factor NF kappa B inhibitor | 0.455 0.052 DBMET01405 0.442 0.055 DBMET01406 | DBMET01405 | |
| 0.032 | 0.317 | 0.076 | Cell adhesion molecule inhibitor | 0.076 0.059 DBMET01405 | DBMET01405 | |
| 0.04 | 0.35 | 0.505 | Angiogenesis stimulant | 0.505 0.011 DBMET01405 0.474 0.013 DBMET01406 | DBMET01405 | |
| 0.089 | 0.409 | 0.134 | CC chemokine 6 receptor antagonist | 0.134 0.057 DBMET01405 0.128 0.077 DBMET01406 | DBMET01405 | |
| 0.051 | 0.374 | 0.276 | Platelet adhesion inhibitor | 0.276 0.041 DBMET01405 0.267 0.044 DBMET01406 | DBMET01405 | |
| 0.02 | 0.349 | 0.059 | Factor IXa inhibitor | 0.055 0.032 DBMET01405 0.059 0.028 DBMET01406 | DBMET01406 | |
| 0.092 | 0.455 | 0.327 | Apoptosis antagonist | 0.326 0.069 DBMET01405 0.327 0.068 DBMET01406 | DBMET01406 | |
| 0.045 | 0.427 | 0.165 | P-glycoprotein inhibitor | 0.165 0.096 DBMET01405 0.162 0.1 DBMET01406 | DBMET01405 | |
| 0.026 | 0.41 | 0.11 | Beta glucuronidase inhibitor | 0.11 0.056 DBMET01405 | DBMET01405 | |
| 0.038 | 0.443 | 0.35 | Free radical scavenger | 0.35 0.039 DBMET01405 0.329 0.044 DBMET01406 | DBMET01405 | |
| 0.065 | 0.496 | 0.432 | Antibacterial | 0.432 0.063 DBMET01405 0.402 0.076 DBMET01406 | DBMET01405 | |
| 0.022 | 0.461 | 0.168 | Lipid peroxidase inhibitor | 0.168 0.056 DBMET01405 0.142 0.074 DBMET01406 | DBMET01405 | |
| 0.092 | 0.552 | 0.571 | Antiinflammatory | 0.571 0.062 DBMET01405 0.567 0.063 DBMET01406 | DBMET01405 | |
| 0.005 | 0.466 | 0.024 | Protein 30S ribosomal subunit inhibitor | 0.024 0.017 DBMET01405 0.023 0.018 DBMET01406 | DBMET01405 | |
| 0.044 | 0.511 | 0.155 | NOS3 expression enhancer | 0.155 0.068 DBMET01405 0.137 0.088 DBMET01406 | DBMET01405 | |
| 0.044 | 0.534 | 0.4 | Immunosuppressant | 0.4 0.063 DBMET01405 0.375 0.074 DBMET01406 | DBMET01405 | |
| 0.012 | 0.534 | 0.134 | Topoisomerase I inhibitor | 0.12 0.055 DBMET01405 0.134 0.048 DBMET01406 | DBMET01406 | |
| 0.029 | 0.576 | 0.264 | Tumour necrosis factor alpha release inhibitor | 0.264 0.068 DBMET01405 0.25 0.075 DBMET01406 | DBMET01405 | |
| 0.029 | 0.719 | 0.318 | Immunomodulator | 0.246 0.118 DBMET01405 0.318 0.073 DBMET01406 | DBMET01406 | |
| 0.007 | 0.788 | 0.166 | Antimitotic | 0.166 0.107 DBMET01405 | DBMET01405 | |
| 0.011 | 0.874 | 0.405 | Apoptosis agonist | 0.405 0.111 DBMET01405 0.401 0.113 DBMET01406 | DBMET01405 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |